Welcome to LookChem.com Sign In|Join Free
  • or
2R,3S-Methyl 4-benzyloxy-3-hydroxy-2-(2E-3-phenyl-2-propen-1-yl)butyrate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

191408-24-9

Post Buying Request

191408-24-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

191408-24-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 191408-24-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,1,4,0 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 191408-24:
(8*1)+(7*9)+(6*1)+(5*4)+(4*0)+(3*8)+(2*2)+(1*4)=129
129 % 10 = 9
So 191408-24-9 is a valid CAS Registry Number.

191408-24-9Downstream Products

191408-24-9Relevant academic research and scientific papers

P1, P2'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors

Duan, James J.-W,Chen, Lihua,Xue, Chu-Biao,Wasserman, Zelda R.,Hardman, Karl D.,Covington, Maryanne B.,Copeland, Robert R.,Arner, Elizabeth C.,Decicco, Carl P.

, p. 1453 - 1458 (1999)

A novel series of 13- and 14-membered macrocyclic amines was developed by linking the P1 and P2' groups. The synthesis entails stereoselective Frater alkylation to install the anti-succinate configuration and macrocyclic amination via nucleophilic displacement. This strategy resulted in a new class of conformationally constrained inhibitors that are potent and selective for MMP-8 and 9 over MMP-1 and 3.

Macrocyclic compounds as metalloprotease inhibitors

-

, (2008/06/13)

This invention relates to macrocyclic molecules which inhibit metalloproteinases, including aggrecanase, and the production of tumor necrosis factor (TNF). In particular, the compounds are inhibitors of metalloproteinases involved in tissue degradation and inhibitors of the release of tumor necrosis factor. The present invention also relates to pharmaceutical compositions comprising such compounds and to methods of using these compounds for the treatment of inflammatory diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 191408-24-9